Медико-биологический
информационный портал
для специалистов
 
Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г.  2020 г.  2021 г.  2022 г.  2023 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 21, Art. 55 (pp. 669-678)    |    2020       
»

Activation of hypoxia-inducible factor in inflammation caused by prolonged exposure to nitrogen dioxide
Kirov Military Medical Academy Russian Federation Defense Ministry, Saint-Petersburg, Russia.



Brief summary

The purpose of the experimental study was to assess the effect of prolonged exposure to nitrogen dioxide on the level of hypoxia-inducible factor activation and the cytoimmunological profile of bronchoalveolar lavage fluid (BALF). Nitrogen dioxide inhalations (30-40 mg/m3) were carried out intermittently (three exposures per day for 30 minutes with a half-hour interval between them) for 60 days. Cell composition, the content of hypoxia-induced factor-1 (HIF-1α), cyclooxygenase-2 (COX-2), interleukin-17 (IL-17), and surfactant protein D (SP-D) were determined in BALF. Under the influence of prolonged exposure to nitrogen dioxide, a persistent inflammatory process was formed in the lungs, as evidenced by the cytoimmunological profile of BALF, and marked activation of hypoxia-induced factor was noted. The results of the study confirm the existence of functional and possibly mutually regulatory relationship of the hypoxic HIF-1α-dependent and pro-inflammatory COX-2-dependent signaling cascades, which can be a therapeutic target for preventing the progression of inflammation and abnormal airway remodeling in many pathological processes associated with the development of inflammatory hypoxia.


Key words

rats, nitrogen dioxide, inflammation, hypoxia-inducible factor, cyclooxygenase-2, interleukin-17, surfactant protein D, lungs.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Dvorakovskaya I.V., Kyzybova N.A., Fionik A.M., Platonova I.S., Lebedeva E.S., Danilov L.N. Patologicheskaya anatomiya bronhov i respiratornoi tkani kris pri vozdeistvii dioksida azota / Pylmonologiya. 2009. 1. S. 54-61.


2. Lyamina S.V., Malishev I.U. Syrfaktantnii belok D v norme i pri zabolevaniyah legkih / Ros. med. jyrn. 2012. 1. S. 50-55.


3. Clerici C., Planès C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells / Am. J. Physiol. Lung Cell Mol. Physiol. 2009. Vol. 296, N 3. P. L267-L274. doi: 10.1152/ajplung.90528.2008.


4. Colgan S.P., Campbell E.L., Kominsky D.J. Hypoxia and mucosal inflammation / Annu. Rev. Pathol. 2016. N 11. P. 77-100. doi: 10.1146/annurev-pathol-012615-044231.


5. Corcoran S.E., O?Neill L.A. HIF1α and metabolic reprogramming in inflammation / J. Clin. Invest. 2016. Vol. 126, N 10. P. 3699-3707. doi: 10.1172/JCI84431.


6. Cummins E.P., Keogh C.E., Crean D., Taylor C.T. The role of HIF in immunity and inflammation / Mol. Aspects Med. 2016. N 47-48. P. 24-34. doi: 10.1016/j.mam.2015.12.004.


7. Eurlings I.M., Reynaert N.L., van den Beucken T., Gosker H.R., de Theije C.C., Verhamme F.M., Bracke K.R., Wouters E.F., Dentener M.A. Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition / PLoS One. 2014. Vol. 9, N 10. e107757. doi: 10.1371/journal.pone.0107757.


8. D?Ignazio L., Bandarra D., Rocha S. NF-κB and HIF crosstalk in immune responses / FEBS J. 2016. Vol. 283, N 3. P. 413-424. doi: 10.1111/febs.13578.


9. Duan M.C., Zhang J.Q., Liang Y., Liu G.N., Xiao J., Tang H.J., Liang Y. Infiltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema / Inflammation. 2016. Vol. 39, N 4. P. 1334-1344. doi: 10.1007/s10753-016-0365-8.


10. Gao W., Li L., Wang Y., Zhang S., Adcock I.M., Barnes P.J., Huang M., Yao X. Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease? / Respirology. 2015. Vol. 20, N 5. P. 722-729. doi: 10.1111/resp.12542.


11. Gu W., Song L., Li X.M., Wang D., Guo X.J., Xu W.G. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways / Sci. Rep. 2015. N 5. P. 8733. doi: 10.1038/srep08733.


12. He X.Y., Shi X.Y., Yuan H.B., Xu H.T., Li Y.K., Zou Z. Propofol attenuates hypoxia-induced apoptosis in alveolar epithelial type II cells through down-regulating hypoxia-inducible factor-1α / Injury. 2012. Vol. 43, N 3. P. 279-283. doi: 10.1016/j.injury.2011.05.037.


13. Huang M., Wang L., Chen J., Bai M., Zhou C., Liu S., Lin Q. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery / Int. J. Oncol. 2016. Vol. 48, N 5. P. 2144-2154. doi: 10.3892/ijo.2016.3421.


14. Jiang H., Zhu Y.S., Xu H., Sun Y. Li Q.F. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B / Am. J. Physiol. Lung Cell Mol. Physiol. 2010. Vol. 298, N 5. P. L660-L669. doi: 10.1152/ajplung.00394.2009.


15. Levänen B., Glader P., Dahlén B., Billing B., Qvarfordt I.,Palmberg L., Larsson K., Lindén A. Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways / Int. J. Chron. Obstruct. Pulmon. Dis. 2016. N 11. P. 2109-2116. doi: 10.2147/COPD.S99900.


16. Lu D., Li N., Yao X., Zhou L. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrom / Bosn. J. Basic. Med. Sci. 2017. Vol. 17, N 1. P. 47-53. doi: 10.17305/bjbms.2016.1579.


17. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodeling / Cardiovasc. Res. 2010. Vol. 86, N 2. P. 236-242. doi: 10.1093/cyr/cvq045.


18. Sin D.D., Pahlavan P.S., Man S.F. Surfactant protein D: A lung specific biomarker in COPD? / Ther. Adv. Respir. Dis. 2008. Vol. 2, N 2. P. 65-74. doi: 10.1177/1753465808088903.


19. Zago M., Rico de Souza A., Hecht E., Rousseau S., Hamid Q., Eidelman D.H., Naglole C.J. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts / Toxicol. Lett. 2014. Vol. 226, N 2. P. 107-116. doi: 10.1016/j.toxlet.2014.01.020.


20. Zhang M., Fei X., Zhang G.Q., Zhang P.Y., Li F., Bao W.P., Zhang Y.Y., Zhou X. Role of neutralizing anti-murine interleukin-17A monoclonal antibody on chronic ozone-induced airway inflammation in mice / Biomed Pharmacother. 2016. N 83. P. 247-256. doi: 10.1016/j.biopha.2016.06.041.








Reference


1. Dvorakovskaya I.V., Kuzubova N.A., Fionik A.M., Platonova I.S., Lebedeva E.S., Danilov L.N. Pathological anatomy of bronchi and rat respiratory tissue when exposed to nitrogen dioxide. Pulmonology / 2009. 1. P. 54-61. [In Russian].


2. Lyamina S.V., Malyshev I.Yu. Surfactant protein D in norma and lung diseases. Rossiyskiy meditsinskiy zhurnal = Russian Medical Journal / 2012. N 1. P. 50-55. [In Russian].


3. Clerici C., Planès C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells / Am. J. Physiol. Lung Cell Mol. Physiol. 2009. Vol. 296, N 3. P. L267-L274. doi: 10.1152/ajplung.90528.2008.


4. Colgan S.P., Campbell E.L., Kominsky D.J. Hypoxia and mucosal inflammation / Annu. Rev. Pathol. 2016. N 11. P. 77-100. doi: 10.1146/annurev-pathol-012615-044231.


5. Corcoran S.E., O?Neill L.A. HIF1α and metabolic reprogramming in inflammation / J. Clin. Invest. 2016. Vol. 126, N 10. P. 3699-3707. doi: 10.1172/JCI84431.


6. Cummins E.P., Keogh C.E., Crean D., Taylor C.T. The role of HIF in immunity and inflammation / Mol. Aspects Med. 2016. N 47-48. P. 24-34. doi: 10.1016/j.mam.2015.12.004.


7. Eurlings I.M., Reynaert N.L., van den Beucken T., Gosker H.R., de Theije C.C., Verhamme F.M., Bracke K.R., Wouters E.F., Dentener M.A. Cigarette smoke extract induces a phenotypic shift in epithelial cells; involvement of HIF1α in mesenchymal transition / PLoS One. 2014. Vol. 9, N 10. e107757. doi: 10.1371/journal.pone.0107757.


8. D?Ignazio L., Bandarra D., Rocha S. NF-κB and HIF crosstalk in immune responses / FEBS J. 2016. Vol. 283, N 3. P. 413-424. doi: 10.1111/febs.13578.


9. Duan M.C., Zhang J.Q., Liang Y., Liu G.N., Xiao J., Tang H.J., Liang Y. Infiltration of IL-17-producing T cells and Treg cells in a mouse model of smoke-induced emphysema / Inflammation. 2016. Vol. 39, N 4. P. 1334-1344. doi: 10.1007/s10753-016-0365-8.


10. Gao W., Li L., Wang Y., Zhang S., Adcock I.M., Barnes P.J., Huang M., Yao X. Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease? / Respirology. 2015. Vol. 20, N 5. P. 722-729. doi: 10.1111/resp.12542.


11. Gu W., Song L., Li X.M., Wang D., Guo X.J., Xu W.G. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways / Sci. Rep. 2015. N 5. P. 8733. doi: 10.1038/srep08733.


12. He X.Y., Shi X.Y., Yuan H.B., Xu H.T., Li Y.K., Zou Z. Propofol attenuates hypoxia-induced apoptosis in alveolar epithelial type II cells through down-regulating hypoxia-inducible factor-1α / Injury. 2012. Vol. 43, N 3. P. 279-283. doi: 10.1016/j.injury.2011.05.037.


13. Huang M., Wang L., Chen J., Bai M., Zhou C., Liu S., Lin Q. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery / Int. J. Oncol. 2016. Vol. 48, N 5. P. 2144-2154. doi: 10.3892/ijo.2016.3421.


14. Jiang H., Zhu Y.S., Xu H., Sun Y. Li Q.F. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B / Am. J. Physiol. Lung Cell Mol. Physiol. 2010. Vol. 298, N 5. P. L660-L669. doi: 10.1152/ajplung.00394.2009.


15. Levänen B., Glader P., Dahlén B., Billing B., Qvarfordt I.,Palmberg L., Larsson K., Lindén A. Impact of tobacco smoking on cytokine signaling via interleukin-17A in the peripheral airways / Int. J. Chron. Obstruct. Pulmon. Dis. 2016. N 11. P. 2109-2116. doi: 10.2147/COPD.S99900.


16. Lu D., Li N., Yao X., Zhou L. Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrom / Bosn. J. Basic. Med. Sci. 2017. Vol. 17, N 1. P. 47-53. doi: 10.17305/bjbms.2016.1579.


17. Rey S., Semenza G.L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodeling / Cardiovasc. Res. 2010. Vol. 86, N 2. P. 236-242. doi: 10.1093/cyr/cvq045.


18. Sin D.D., Pahlavan P.S., Man S.F. Surfactant protein D: A lung specific biomarker in COPD? / Ther. Adv. Respir. Dis. 2008. Vol. 2, N 2. P. 65-74. doi: 10.1177/1753465808088903.


19. Zago M., Rico de Souza A., Hecht E., Rousseau S., Hamid Q., Eidelman D.H., Naglole C.J. The NF-κB family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts / Toxicol. Lett. 2014. Vol. 226, N 2. P. 107-116. doi: 10.1016/j.toxlet.2014.01.020.


20. Zhang M., Fei X., Zhang G.Q., Zhang P.Y., Li F., Bao W.P., Zhang Y.Y., Zhou X. Role of neutralizing anti-murine interleukin-17A monoclonal antibody on chronic ozone-induced airway inflammation in mice / Biomed Pharmacother. 2016. N 83. P. 247-256. doi: 10.1016/j.biopha.2016.06.041.





Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100